Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

HC Surgical Specialists Yönetim

Yönetim kriter kontrolleri 2/4

HC Surgical Specialists' CEO'su Sieu Min Heah, Sep2015 tarihinde atandı, in görev süresi 9.08 yıldır. şirketin hisselerinin 41.6% doğrudan sahiptir ve bu hisselerin değeri SGD 17.92M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.5 yıl ve 8.1 yıldır.

Anahtar bilgiler

Sieu Min Heah

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	9.1yrs
CEO sahipliği	41.6%
Yönetim ortalama görev süresi	5.5yrs
Yönetim Kurulu ortalama görev süresi	8.1yrs

Son yönetim güncellemeleri

Recent updates

CEO

Sieu Min Heah (60 yo)

9.1yrs

Görev süresi

Dr. Sieu Min Heah, MB BCh, FRCSEd (General Surgery), FAMS General Surgery, has been Chief Executive Officer and Executive Director of HC Surgical Specialists Limited since September 1, 2015.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sieu Min Heah	CEO & Executive Director	9.1yrs	Veri yok	41.6% SGD 17.9m
Soo Ling Ong	Chief Financial Officer	8.7yrs	Veri yok	Veri yok
Josephine Tio Melissa	Chief Operating Officer	2.4yrs	Veri yok	Veri yok
Kok Hoong Chia	Medical Director & Executive Director	no data	Veri yok	22.6% SGD 9.7m
Gary Ng	Head of the Internal Audit	no data	Veri yok	Veri yok
Hui Theng Lee	Chief Nursing Officer	1.4yrs	Veri yok	0.065% SGD 28.0k
Moi Heyang Lin	Joint Company Secretary	no data	Veri yok	Veri yok
Pei Chan Tang	Joint Company Secretary	no data	Veri yok	Veri yok

5.5yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: 1B1 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sieu Min Heah	CEO & Executive Director	9.1yrs	Veri yok	41.6% SGD 17.9m
Kok Hoong Chia	Medical Director & Executive Director	9.1yrs	Veri yok	22.6% SGD 9.7m
Seng Soon Ooi	Independent Non-Executive Director	8.1yrs	Veri yok	Veri yok
Weng Hoe Chong	Independent Non-Executive Chairman	8.1yrs	Veri yok	0.11% SGD 46.9k
Chye Lai Lim	Non-Independent Non-Executive Director	8.1yrs	Veri yok	0.16% SGD 70.0k

8.1yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1B1 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.1 yıldır).

HC Surgical Specialists Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

Insufficient new directors

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Insufficient new directors

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: S$0.025 (vs S$0.02 in FY 2023)

HC Surgical Specialists Limited Proposes Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2024, Payable on 25 November 2024

New minor risk - Financial data availability

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

First half 2024 earnings released: EPS: S$0.023 (vs S$0.014 in 1H 2023)

HC Surgical Specialists Limited Declares Interim Dividend for the Financial Year Ending 31 May 2024, Payable on 13 March 2024

HC Surgical Specialists Limited Declares Interim Dividend, Payable on 13 March 2024

Insufficient new directors

Upcoming dividend of S$0.01 per share at 6.3% yield

HC Surgical Specialists Limited Approves A Final Dividend for the Financial Year Ended 31 May 2023

New minor risk - Shareholder dilution

HC Surgical Specialists Limited Proposes Final Dividend for the Financial Year Ended 31 May 2023

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Full year 2023 earnings released: EPS: S$0.019 (vs S$0.043 in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.01 per share at 4.9% yield

HC Surgical Specialists Limited Announces Interim Dividend for the Financial Year Ending 31 May 2023, Payable on 13 March 2023

First half 2023 earnings released

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.012 per share

HC Surgical Specialists Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2022

Now 21% undervalued after recent price drop

HC Surgical Specialists Limited, Annual General Meeting, Sep 27, 2022

Full year 2022 earnings released: EPS: S$0.043 (vs S$0.053 in FY 2021)

HC Surgical Specialists Limited Recommends Final Dividend for the Financial Year Ended May 31, 2022

HC Surgical Specialists Limited Appoints Melissa Josephine Tio @ Melissa Josephine Susantio as Chief Operating Officer, Effective 1 May 2022

Insufficient new directors

HC Surgical Specialists Limited Announces Resignation of Chief Operating Officer, Ouyang Yuxia, Connie, Effective 30 April 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of S$0.023 per share

Upcoming dividend of S$0.023 per share

Full year 2021 earnings released: EPS S$0.053 (vs S$0.027 in FY 2020)

HC Surgical Specialists Limited Announces That the Court of Appeal Dismissed

First half 2021 earnings released: EPS S$0.033

New 90-day high: S$0.42

HC Surgical Specialists Limited (Catalist:1B1) agreed to acquire remaining 30% stake in Julian Ong Endoscopy & Surgery (Pte Ltd).

HC Surgical Specialists Limited (Catalist:1B1) acquired 20% stake in Healthcare Essentials Pte. Ltd. from Lim Chye Lai, Gjan for SGD 0.18 million.

HC Surgical Specialists Provides Cashless and Convenient Healthcare Services to Eligible 1 Customers of Prudential Singapore

New 90-day high: S$0.35

New 90-day high - S$0.34

Full year earnings released - EPS S$0.023

New 90-day low - S$0.29

HC Surgical Specialists Limited completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery (Pte Ltd) from Julian Ong Surgery Pte. Ltd. for $3.8 million.

HC Surgical Specialists Limited (Catalist:1B1) completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery Pte. Ltd from Julian Ong Surgery Pte. Ltd.

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş